NCT03348423View on ClinicalTrials.gov

Evaluation of DEX-IN During Outpatient Procedures

PHASE2CompletedINTERVENTIONAL

Enrollment

45

Participants

Timeline

Start Date

November 15, 2017

Primary Completion Date

January 18, 2018

Study Completion Date

January 18, 2018

Conditions

Pain

Interventions

DRUG

DEX-IN

IN Dexmedetomidine + IV placebo

DRUG

Fentanyl

IN Placebo + IV Fentanyl

DRUG

Placebo

IN Placebo + IV Placebo

Trial Locations (1)

91105

Research Center, Pasadena

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Baudax Bio

INDUSTRY

NCT03348423 - Evaluation of DEX-IN During Outpatient Procedures | Biotech Hunter | Biotech Hunter